Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023178 · ClinicalTrials.gov registry record · NA
Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01023178: Completed NA study, sponsored by Stanford University.
NCT01023178 is a NA study that has completed, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01023178, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
To directly compare the safety (by laboratory evaluation) and efficacy (feminization and growth) of three commonly used estrogen preparations in adolescent patients with ovarian failure, either due to congenital causes (Turner syndrome) or medical therapies. We hypothesize that transdermal estrogen will have equivalent efficacy and a more favorable safety profile in comparison with conventional oral estrogen replacement.
Interventions
- DRUG 17beta Estradiol
- DRUG Conjugated estrogens
- DRUG 17Beta Estradiol - transdermal
- DRUG Progesterone, micronized
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-02 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01023178
The ClinicalTrials.gov registry entry for NCT01023178 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which 17beta Estradiol is the first listed.
NCT01023178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01023178 about?
NCT01023178 is a clinical study titled "Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure". To directly compare the safety (by laboratory evaluation) and efficacy (feminization and growth) of three commonly used estrogen preparations in adolescent patients with ovarian failure, either due to congenital causes (Turner syndrome) or medical therapies. We hypothesize that transdermal estrogen ...
What is the current status of trial NCT01023178?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-02. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01023178?
The interventions under investigation include: 17beta Estradiol (DRUG), Conjugated estrogens (DRUG), 17Beta Estradiol - transdermal (DRUG), Progesterone, micronized (DRUG).
Who is sponsoring clinical trial NCT01023178?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.